Trial Profile
Efficacy and tolerability of docetaxel + S-1 vs docetaxel + cisplatin first-line therapy in patients with advanced gastric cancer with an evaluation of SPARC expression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2011
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Pharmacogenomic; Therapeutic Use
- 05 Nov 2010 New trial record.